D. E. Shaw & Co., Inc. Morphic Holding, Inc. Transaction History

D. E. Shaw & Co., Inc.

$107 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$26.12 - $34.07 $1.61 Million - $2.1 Million	-61,637 Reduced 28.74%	152,819 $5.21 Million
Q1 2024 May 15, 2024	SELL	$26.64 - $40.31 $2.33 Million - $3.52 Million	-87,445 Reduced 28.96%	214,456 $7.55 Million
Q4 2023 Feb 14, 2024	BUY	$19.95 - $31.0 $3.15 Million - $4.9 Million	157,943 Added 109.71%	301,901 $8.72 Million
Q3 2023 Nov 14, 2023	SELL	$21.33 - $59.42 $483,124 - $1.35 Million	-22,650 Reduced 13.59%	143,958 $3.3 Million
Q2 2023 Aug 14, 2023	BUY	$34.33 - $62.11 $3.66 Million - $6.62 Million	106,592 Added 177.61%	166,608 $9.55 Million
Q1 2023 May 15, 2023	BUY	$26.01 - $48.69 $931,496 - $1.74 Million	35,813 Added 147.97%	60,016 $2.26 Million
Q4 2022 Feb 14, 2023	SELL	$24.14 - $30.37 $517,875 - $651,527	-21,453 Reduced 46.99%	24,203 $647,000
Q3 2022 Nov 14, 2022	BUY	$22.23 - $33.37 $160,100 - $240,330	7,202 Added 18.73%	45,656 $1.29 Million
Q2 2022 Aug 15, 2022	BUY	$19.74 - $43.01 $532,545 - $1.16 Million	26,978 Added 235.08%	38,454 $834,000
Q1 2022 May 16, 2022	SELL	$36.25 - $52.02 $518,375 - $743,886	-14,300 Reduced 55.48%	11,476 $461,000
Q4 2021 Feb 14, 2022	SELL	$43.27 - $65.72 $1.19 Million - $1.81 Million	-27,480 Reduced 51.6%	25,776 $1.22 Million
Q3 2021 Nov 15, 2021	SELL	$53.61 - $67.5 $2.05 Million - $2.59 Million	-38,305 Reduced 41.84%	53,256 $3.02 Million
Q2 2021 Aug 16, 2021	SELL	$45.13 - $64.99 $1.68 Million - $2.42 Million	-37,254 Reduced 28.92%	91,561 $5.26 Million
Q1 2021 May 17, 2021	BUY	$29.77 - $84.85 $2.21 Million - $6.31 Million	74,373 Added 136.61%	128,815 $8.15 Million
Q4 2020 Feb 16, 2021	BUY	$25.66 - $34.55 $400,142 - $538,772	15,594 Added 40.14%	54,442 $1.83 Million
Q3 2020 Nov 16, 2020	SELL	$22.51 - $30.11 $78,942 - $105,595	-3,507 Reduced 8.28%	38,848 $1.06 Million
Q2 2020 Aug 14, 2020	SELL	$12.65 - $29.57 $20,265 - $47,371	-1,602 Reduced 3.64%	42,355 $1.15 Million
Q1 2020 May 15, 2020	BUY	$10.84 - $20.85 $476,493 - $916,503	43,957 New	43,957 $645,000

Others Institutions Holding MORF

# of Institutions

Shares Held

4.96M

Call Options Held

Put Options Held

View Full List

About Morphic Holding, Inc.

Ticker MORF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,477,100
Market Cap $2.19B
Description
Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...

More about MORF

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account